| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |